PRLD
Prelude Therapeutics Incorporated
NASDAQHealthcareBiotechnologyUS
USD3.66
+0.16 (+4.57%)
Rating:C
Company Profile
CEO
Krishna Vaddi
IPO Date
2020-09-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$3.49
Prev. Close
$3.50
Day Low
$3.40
Day High
$3.72
52W Low
$0.75
52W High
$5.54
Market Cap
$0.21B
Volume
0.38M